中成药序贯疗法治疗腔隙性脑梗死疗效观察.docVIP

中成药序贯疗法治疗腔隙性脑梗死疗效观察 　　摘 要 目的：观察丹参酮、血塞通、中风回春丸、银丹心脑通软胶囊序贯疗法对腔隙性脑梗死的治疗效果。方法：选择2013年5月―2014年3月诊治的腔隙性脑梗死患者60例，在其头晕、耳鸣、肢体麻木等症发作时先每天静脉滴注丹参酮ⅡA磺酸钠50 mg及血塞通（冻干）0.4 g，连续14 d，停用补液后每日3次口服中风回春丸1袋（1.8 g）及银丹心脑通软胶囊2粒（0.4g/粒），连用6个月。比较治疗前后患者的症状变化。结果：治疗总有效率为81.7%（49/60），有效患者症状均有不同程度减轻，有3例出现不良反应。51例（85%）患者服药依从性良好。结论：丹参酮ⅡA磺酸钠注射液、血塞通（冻干）、中风回春丸、银丹心脑通软胶囊序贯疗法具有明显缓解腔隙性脑梗死患者症状的作用，是安全有效的临床治疗手段之一。 　　关键词 腔隙性脑梗死； 序贯疗法； 中成药 　　中图分类号：R743.33 文献标志码：A 文章编号：1006-1533（2016）24-0023-03 　　Observation of the effect of the Chinese patent medicine sequential therapy in the treatment of lacunar cerebral infarction 　　SHEN Chunfeng 　　（Liantang Community Health Service Center of Qingpu District， Shanghai 201715， China） 　　ABSTRACT Objective： To observe the therapeutic effect of the sequential therapy of tanshinone， xuesaitong， zhongfenghuichun pill， and yindanxinnaotong capsule in the treatment of lacunar cerebral infarction. Methods： From May 2013 to March 2014， 60 cases of lacunar cerebral infarction that had been diagnosed and treated were selected. When they had the attacks of dizziness， tinnitus， limb numbness and other symptoms， they were intravenously infused with sodium tanshinone II A sulfonate 50 mg and xuesaitong（freeze-drying） 0.4 g once a day for 14 days. After cessation of fluid infusion， the patients took 1 bag of zhongfenghuichun pill（1.8g）and 2 soft capsule of yindanxinnaotong（0.4g/g）tid orally for six months. The changes of symptoms were compared before and after treatment in the patients. Results： The total effective rate was 81.7%（49/60）， the symptoms of the patients were effectively reduced to varying degrees， and there were 3 cases of adverse reactions. Fifty cases（85%）had good compliance. Conclusion： The sequential therapy of tanshinone， xuesaitong， zhongfenghuichun pill， and yindanxinnaotong capsule has the role of relieving the symptoms of the patients with lacunar cerebral infarction and is one of the safe and effective clinical treatments. 　　KEY WORDS lacunar cerebral infarcti